RR

Rosanne Robinson

Clarity Pharmaceuticals Ltd | Lead Independent Director, Non-Executive Director
Ms Robinson brings over 25 years of board and executive leadership across the nuclear medicine, biotech, and health sectors, with expertise in commercial strategy, operational oversight, governance and stakeholder engagement across both public and private enterprises. She previously served as Chief Operating Officer of Cyclotek (Aust) Pty Ltd, where she led multi-site operations for radiopharmaceutical manufacturing across Australia and New Zealand. Prior to that, she was General Manager, Business Development at the Australian Nuclear Science and Technology Organisation (ANSTO).

Company and Roles

Company
Title
Tenure
Since
CU6
CU6
Clarity Pharmaceuticals Ltd
  • Lead Independent Director
  • Non-Executive Director
15yrs, 8mthOct 2010

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CU6
CU6
Clarity Pharmaceuticals Ltd
30/06/25178,079N/A17,080N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CU6
CU6
Clarity Pharmaceuticals Ltd
20/11/24
Issued
17,080$5.446$93,018Issue of options
CU6
CU6
Clarity Pharmaceuticals Ltd
17/09/24
Exercise
200,000$0.825$165,000Exercise of options
CU6
CU6
Clarity Pharmaceuticals Ltd
17/09/24
Buy
178,079$0.927$165,000Exercise of options